Page last updated: 2024-11-02
pirenzepine and Stammering
pirenzepine has been researched along with Stammering in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Lavid, N | 1 |
| Franklin, DL | 1 |
| Maguire, GA | 1 |
Other Studies
1 other study available for pirenzepine and Stammering
| Article | Year |
|---|---|
Management of child and adolescent stuttering with olanzapine: three case reports.
Topics: Adolescent; Benzodiazepines; Child; Dose-Response Relationship, Drug; Humans; Male; Olanzapine; Pire | 1999 |